Developer docs
API playgroundTry for free, no card

Search company profiles

UNM Comprehensive Cancer Center

Full company profile

uuid002b8en

Namestring
UNM Comprehensive Cancer Center
Legal namestring
UNM Health System
Websiteurl
unmhealth.org
Company typeenum
Public
Founded yearint
1971
Descriptiontext

UNM Comprehensive Cancer Center is the only National Cancer Institute-designated cancer center in New Mexico, operating as a public academic medical center within the University of New Mexico Health Sciences Center. The center provides comprehensive cancer care spanning medical oncology, surgical oncology, radiation oncology, immunotherapy, chemotherapy, and clinical trials, serving patients across New Mexico who would otherwise need to leave the state for NCI-level care. Care is delivered through a dedicated cancer facility at 1201 Camino de Salud NE in Albuquerque and integrated into a larger delivery network that includes UNM Hospital (New Mexico's only Level 1 trauma center), UNM Sandoval Regional Medical Center, UNM Children's Hospital, and 76 outpatient clinic locations under UNM Medical Group.

The underlying technology stack is conventional enterprise healthcare IT rather than proprietary platform infrastructure: Cerner Millennium EMR serves as the enterprise electronic medical record for the broader UNM Health System, while MOSAIQ Oncology EMR provides oncology-specific treatment planning and off-campus access for practitioners. Patient access is supported by centralized scheduling, provider referral portals (including a Provider Portal for referring physicians), and 25 documented telehealth offerings that extend oncology reach into rural and tribal communities across the state. Patient engagement tools include the UNM Health mobile wayfinding app and the MyHealthUNM patient portal.

Revenue is generated primarily through fee-for-service patient care billed under CMS-compliant standard charge schedules, with gross charges, payer-negotiated rates, and cash prices publicly disclosed for price transparency. Cost estimates are available through a Self-Service Patient Estimate tool, and financial assistance programs address uninsured populations. Research revenue flows through the NCI Cancer Center Support Grant and consortium-based funding, including an initial $40M allocation to UNM CCC as part of the C-Further international pediatric oncology consortium in partnership with UVA Comprehensive Cancer Center, Dana-Farber Cancer Institute, Mass General Brigham, MiNK Therapeutics, University of Southampton, Cancer Research Horizons, LifeArc, and Great Ormond Street Hospital Charity. UNM Health reports 1M+ patient visits annually, and the broader system employs 1,627 providers, of which UNM Medical Group contributes 1,100+ practitioners across 152 specialties.

Short descriptiontext

UNM Comprehensive Cancer Center is the only NCI-designated cancer center in New Mexico, providing chemotherapy, surgery, radiation, immunotherapy, and clinical trials to cancer patients statewide as part of UNM Health System.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersAlbuquerque, United States
HQ citystring
Albuquerque
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
comprehensive cancer care, oncology clinical trials, radiation therapy services, immunotherapy treatment, NCI cancer research
Industry3 codes
1Ambulatory Oncology Centers (Outpatient Chemo/Radiation)
CodeHLAFABAIPrimaryYes
2Oncology & Cancer Specialty Hospitals
CodeHLAFAHACPrimaryNo
3Medical Oncology
CodeHLAKAFABPrimaryNo
NAICS code3 codes
  • Ambulatory Health Care Services621
  • Specialty (except Psychiatric and Substance Abuse) Hospitals622310
  • Offices of Physicians62111
SIC code3 codes
  • Services-Specialty Outpatient Facilities, Nec8093
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Health Services8000
Product category
Oncology/Cancer Care Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Patient Care Services
TypeSubscription Recurring
Description

Healthcare services provided to patients including inpatient, outpatient, emergency, and specialty care. UNM Hospital serves 1M+ patient visits annually as New Mexico's only Level 1 trauma center.

unmhealth.org
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Pricing details1 tier
1Standard hospital charges published for transparency
ModelOtherBilling cadencePay-as-you-go
Notes

Gross charges, payer-negotiated rates, and cash prices are published. Cost estimates available via Self-Service Patient Estimate tool (24/7) or by phone: UNMH (505-925-0900), CRTC (505-925-0336), SRMC (505-994-7157). Financial assistance available.

unmhealth.org
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

The UNM Comprehensive Cancer Center is the only NCI-designated cancer center in New Mexico, providing comprehensive cancer treatment (chemotherapy, surgery, radiation therapy, immunotherapy), clinical trials, cancer research, survivorship care, and support services. It operates as the oncology specialty hub of the UNM Health Sciences Center, delivering academic, research-backed cancer care to patients across the state, including rural and Native American communities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 1M+ patient visits annually across UNM Health System
Product overview1 text field

UNM Comprehensive Cancer Center is a single healthcare service offering - an NCI-designated cancer center that provides comprehensive cancer treatment, research, and clinical care services to patients in New Mexico. It operates as part of the UNM Health System.

Product and service5 records
1Comprehensive Cancer Treatment Services
CategoryCancer Treatment
Description

Comprehensive cancer care including medical oncology, surgical oncology, radiation oncology, immunotherapy, and chemotherapy provided at the only NCI-designated cancer center in New Mexico. For adult and pediatric patients throughout the state.

2Clinical Trials
CategoryClinical Research
Description

Access to National Cancer Institute-sponsored oncology clinical trials, including pediatric programs such as C-Further CF-012 for Ewing sarcoma and CF-033 for bone sarcoma, medulloblastoma, and acute myeloid leukemia. Open to qualifying cancer patients in New Mexico.

3Cancer Survivorship and Support Services
CategoryPatient Support Services
Description

Post-treatment survivorship care, patient navigation, and support services for cancer patients and families. Designed for patients completing cancer treatment at UNM Comprehensive Cancer Center.

4Oncology Telehealth Services
CategoryTelehealth
Description

25 telehealth offerings enabling remote oncology consultations and follow-up care for cancer patients across New Mexico, particularly serving rural and Native American communities who otherwise lack local specialty access.

524/7 Emergency and ICU Cancer Care
CategoryEmergency Oncology Care
Description

24/7 emergency and ICU expertise for complex oncology emergencies at New Mexico's only Level 1 trauma center, part of UNM Hospital. For cancer patients requiring emergency intervention across the region.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-10
Description

C-Further consortium partnered with UVA Comprehensive Cancer Center for CF-012 pediatric oncology program targeting Ewing sarcoma. This is part of an international consortium dedicated to childhood cancer therapeutics with an initial $40 million budget.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-10
Description

C-Further consortium partnered with Dana-Farber Cancer Institute for CF-012 pediatric oncology program targeting Ewing sarcoma. Dana-Farber provides clinical expertise for the pediatric oncology research consortium.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-10
Description

C-Further consortium partnered with Mass General Brigham for CF-012 pediatric oncology program targeting Ewing sarcoma, contributing to the international childhood cancer therapeutics initiative.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-10
Description

C-Further consortium partnered with MiNK Therapeutics for CF-033 pediatric oncology program targeting multiple children's cancers including bone sarcoma, medulloblastoma, and acute myeloid leukemia.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-10
Description

C-Further consortium partnered with University of Southampton for CF-033 pediatric oncology program. The consortium is supported by core partners Cancer Research Horizons, LifeArc, and Great Ormond Street Hospital Charity.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-10
Description

Core supporting partner of C-Further international consortium dedicated to childhood cancer therapeutics with an initial budget of $40 million (£30 million).

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-10
Description

Core supporting partner of C-Further international consortium dedicated to childhood cancer therapeutics with an initial budget of $40 million (£30 million).

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-10
Description

Core supporting partner of C-Further international consortium dedicated to childhood cancer therapeutics with an initial budget of $40 million (£30 million).

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

NCI-designated Comprehensive Cancer Center within a large academic medical system. Comparable to UNM in NCI designation and academic model, with a broader portfolio of subspecialty oncology services and a national referral base.

TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center affiliated with UW Medicine, focused on translational research, immunotherapy, and clinical trials. Comparable to UNM in NCI-designation scope and academic medical-center integration.

TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center integrated within an academic medical system, offering the same medical, surgical, and radiation oncology plus clinical-trial portfolio as UNM, with a multi-state geographic footprint.

TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center specializing in multidisciplinary oncology care, translational research, and clinical trials. Closest functional peer to UNM Comprehensive Cancer Center in terms of care model and research orientation.

TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center at the University of Utah serving a primarily rural Western catchment. Closely comparable to UNM in academic medical center structure, NCI designation, and geographic reach into underserved populations.

TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center operating as a standalone specialty hospital. Comparable to UNM Comprehensive Cancer Center in research-driven oncology services, clinical trials, and multidisciplinary care.

TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center integrated within an academic medical center. Comparable to UNM Comprehensive Cancer Center in combining research, clinical trials, and multidisciplinary oncology care.

TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center affiliated with Harvard Medical School and a C-Further consortium partner of UNM. Comparable as a research-intensive oncology center providing clinical trials and subspecialty cancer care.

TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center and academic oncology institution. Directly comparable as a research-driven cancer center providing medical, surgical, and radiation oncology plus clinical trials, though operating at a far larger national scale.

TypeDirect peer
Description

NCI-designated cancer center and a C-Further consortium partner of UNM. Directly comparable as a university-affiliated oncology program providing clinical trials and multidisciplinary cancer care.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

UNM Comprehensive Cancer Center

Oncology/Cancer Care Servicesunmhealth.org

UNM Comprehensive Cancer Center is the only NCI-designated cancer center in New Mexico, providing chemotherapy, surgery, radiation, immunotherapy, and clinical trials to cancer patients statewide as part of UNM Health System.

What UNM Comprehensive Cancer Center does

UNM Comprehensive Cancer Center is the only National Cancer Institute-designated cancer center in New Mexico, operating as a public academic medical center within the University of New Mexico Health Sciences Center. The center provides comprehensive cancer care spanning medical oncology, surgical oncology, radiation oncology, immunotherapy, chemotherapy, and clinical trials, serving patients across New Mexico who would otherwise need to leave the state for NCI-level care. Care is delivered through a dedicated cancer facility at 1201 Camino de Salud NE in Albuquerque and integrated into a larger delivery network that includes UNM Hospital (New Mexico's only Level 1 trauma center), UNM Sandoval Regional Medical Center, UNM Children's Hospital, and 76 outpatient clinic locations under UNM Medical Group.

The underlying technology stack is conventional enterprise healthcare IT rather than proprietary platform infrastructure: Cerner Millennium EMR serves as the enterprise electronic medical record for the broader UNM Health System, while MOSAIQ Oncology EMR provides oncology-specific treatment planning and off-campus access for practitioners. Patient access is supported by centralized scheduling, provider referral portals (including a Provider Portal for referring physicians), and 25 documented telehealth offerings that extend oncology reach into rural and tribal communities across the state. Patient engagement tools include the UNM Health mobile wayfinding app and the MyHealthUNM patient portal.

Revenue is generated primarily through fee-for-service patient care billed under CMS-compliant standard charge schedules, with gross charges, payer-negotiated rates, and cash prices publicly disclosed for price transparency. Cost estimates are available through a Self-Service Patient Estimate tool, and financial assistance programs address uninsured populations. Research revenue flows through the NCI Cancer Center Support Grant and consortium-based funding, including an initial $40M allocation to UNM CCC as part of the C-Further international pediatric oncology consortium in partnership with UVA Comprehensive Cancer Center, Dana-Farber Cancer Institute, Mass General Brigham, MiNK Therapeutics, University of Southampton, Cancer Research Horizons, LifeArc, and Great Ormond Street Hospital Charity. UNM Health reports 1M+ patient visits annually, and the broader system employs 1,627 providers, of which UNM Medical Group contributes 1,100+ practitioners across 152 specialties.

UNM Comprehensive Cancer Center firmographics

Firmographics
Name
UNM Comprehensive Cancer Center
Legal name
UNM Health System
Website
https://unmhealth.org
Company type
Public
Founded year
1971
Operating status
Operating
Headcount range
501–1,000 employees
Short description
UNM Comprehensive Cancer Center is the only NCI-designated cancer center in New Mexico, providing chemotherapy, surgery, radiation, immunotherapy, and clinical trials to cancer patients statewide as part of UNM Health System.
Ownership category
akta.pro rank

UNM Comprehensive Cancer Center industry classification

Industry
Product category
Oncology/Cancer Care Services
NAICS
Ambulatory Health Care Services (621), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Offices of Physicians (62111)
SIC
Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
akta.pro primary industry
Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)
akta.pro secondary industries
Oncology & Cancer Specialty Hospitals (HLAFAHAC), Medical Oncology (HLAKAFAB)

Keywords

  • Comprehensive cancer care
  • Oncology clinical trials
  • Radiation therapy services
  • Immunotherapy treatment
  • NCI cancer research

Where UNM Comprehensive Cancer Center is headquartered

Location

Headquarters

HQ city
Albuquerque
HQ country
United States
HQ region
North America

Offices3 records

Markets served

UNM Comprehensive Cancer Center business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Patient Care Services: Healthcare services provided to patients including inpatient, outpatient, emergency, and specialty care. UNM Hospital serves 1M+ patient visits annually as New Mexico's only Level 1 trauma center.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goStandard hospital charges published for transparency

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

UNM Comprehensive Cancer Center product offering

Product offering

Core offering

The UNM Comprehensive Cancer Center is the only NCI-designated cancer center in New Mexico, providing comprehensive cancer treatment (chemotherapy, surgery, radiation therapy, immunotherapy), clinical trials, cancer research, survivorship care, and support services. It operates as the oncology specialty hub of the UNM Health Sciences Center, delivering academic, research-backed cancer care to patients across the state, including rural and Native American communities.

Product overview

UNM Comprehensive Cancer Center is a single healthcare service offering - an NCI-designated cancer center that provides comprehensive cancer treatment, research, and clinical care services to patients in New Mexico. It operates as part of the UNM Health System.

Differentiator

Problem solved

Functional benefit

Products and services

  • Comprehensive Cancer Treatment Services Comprehensive cancer care including medical oncology, surgical oncology, radiation oncology, immunotherapy, and chemotherapy provided at the only NCI-designated cancer center in New Mexico. For adult and pediatric patients throughout the state.
  • Clinical Trials Access to National Cancer Institute-sponsored oncology clinical trials, including pediatric programs such as C-Further CF-012 for Ewing sarcoma and CF-033 for bone sarcoma, medulloblastoma, and acute myeloid leukemia. Open to qualifying cancer patients in New Mexico.
  • Cancer Survivorship and Support Services Post-treatment survivorship care, patient navigation, and support services for cancer patients and families. Designed for patients completing cancer treatment at UNM Comprehensive Cancer Center.
  • Oncology Telehealth Services 25 telehealth offerings enabling remote oncology consultations and follow-up care for cancer patients across New Mexico, particularly serving rural and Native American communities who otherwise lack local specialty access.
  • 24/7 Emergency and ICU Cancer Care 24/7 emergency and ICU expertise for complex oncology emergencies at New Mexico's only Level 1 trauma center, part of UNM Hospital. For cancer patients requiring emergency intervention across the region.

Quantifiable outcome

  • 1M+ patient visits annually across UNM Health System

Companies that use UNM Comprehensive Cancer Center

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles2 records

UNM Comprehensive Cancer Center technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

UNM Comprehensive Cancer Center partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core.

  • UVA Comprehensive Cancer CentercoreStrategic or Co-development Partner · 10 March 2026C-Further consortium partnered with UVA Comprehensive Cancer Center for CF-012 pediatric oncology program targeting Ewing sarcoma. This is part of an international consortium dedicated to childhood cancer therapeutics with an initial $40 million budget.
  • Dana-Farber Cancer InstitutecoreStrategic or Co-development Partner · 10 March 2026C-Further consortium partnered with Dana-Farber Cancer Institute for CF-012 pediatric oncology program targeting Ewing sarcoma. Dana-Farber provides clinical expertise for the pediatric oncology research consortium.
  • Mass General BrighamcoreStrategic or Co-development Partner · 10 March 2026C-Further consortium partnered with Mass General Brigham for CF-012 pediatric oncology program targeting Ewing sarcoma, contributing to the international childhood cancer therapeutics initiative.
  • MiNK TherapeuticscoreStrategic or Co-development Partner · 10 March 2026C-Further consortium partnered with MiNK Therapeutics for CF-033 pediatric oncology program targeting multiple children's cancers including bone sarcoma, medulloblastoma, and acute myeloid leukemia.
  • University of SouthamptoncoreStrategic or Co-development Partner · 10 March 2026C-Further consortium partnered with University of Southampton for CF-033 pediatric oncology program. The consortium is supported by core partners Cancer Research Horizons, LifeArc, and Great Ormond Street Hospital Charity.
  • Cancer Research HorizonscoreStrategic or Co-development Partner · 10 March 2026Core supporting partner of C-Further international consortium dedicated to childhood cancer therapeutics with an initial budget of $40 million (£30 million).
  • LifeArccoreStrategic or Co-development Partner · 10 March 2026Core supporting partner of C-Further international consortium dedicated to childhood cancer therapeutics with an initial budget of $40 million (£30 million).
  • Great Ormond Street Hospital CharitycoreStrategic or Co-development Partner · 10 March 2026Core supporting partner of C-Further international consortium dedicated to childhood cancer therapeutics with an initial budget of $40 million (£30 million).

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

UNM Comprehensive Cancer Center competitors and assessment

Company assessment

Broad incumbents

  • Stanford Cancer Institute: NCI-designated Comprehensive Cancer Center within a large academic medical system. Comparable to UNM in NCI designation and academic model, with a broader portfolio of subspecialty oncology services and a national referral base.

Direct peers

  • Fred Hutchinson Cancer Center: NCI-designated Comprehensive Cancer Center affiliated with UW Medicine, focused on translational research, immunotherapy, and clinical trials. Comparable to UNM in NCI-designation scope and academic medical-center integration.
  • Mayo Clinic Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center integrated within an academic medical system, offering the same medical, surgical, and radiation oncology plus clinical-trial portfolio as UNM, with a multi-state geographic footprint.
  • Memorial Sloan Kettering Cancer Center: NCI-designated Comprehensive Cancer Center specializing in multidisciplinary oncology care, translational research, and clinical trials. Closest functional peer to UNM Comprehensive Cancer Center in terms of care model and research orientation.
  • Huntsman Cancer Institute: NCI-designated Comprehensive Cancer Center at the University of Utah serving a primarily rural Western catchment. Closely comparable to UNM in academic medical center structure, NCI designation, and geographic reach into underserved populations.
  • Roswell Park Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center operating as a standalone specialty hospital. Comparable to UNM Comprehensive Cancer Center in research-driven oncology services, clinical trials, and multidisciplinary care.
  • Duke Cancer Institute: NCI-designated Comprehensive Cancer Center integrated within an academic medical center. Comparable to UNM Comprehensive Cancer Center in combining research, clinical trials, and multidisciplinary oncology care.
  • Dana-Farber Cancer Institute: NCI-designated Comprehensive Cancer Center affiliated with Harvard Medical School and a C-Further consortium partner of UNM. Comparable as a research-intensive oncology center providing clinical trials and subspecialty cancer care.
  • MD Anderson Cancer Center: NCI-designated Comprehensive Cancer Center and academic oncology institution. Directly comparable as a research-driven cancer center providing medical, surgical, and radiation oncology plus clinical trials, though operating at a far larger national scale.
  • University of Virginia Cancer Center: NCI-designated cancer center and a C-Further consortium partner of UNM. Directly comparable as a university-affiliated oncology program providing clinical trials and multidisciplinary cancer care.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

UNM Comprehensive Cancer Center social profiles

Digital presence

UNM Comprehensive Cancer Center financial estimates

Financial estimate

Revenue estimate

Valuation estimate

UNM Comprehensive Cancer Center leadership team

Management profile

Number of profiles

UNM Comprehensive Cancer Center subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

UNM Comprehensive Cancer Center funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

UNM Comprehensive Cancer Center M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UNM Comprehensive Cancer Center

What does UNM Comprehensive Cancer Center do?

The UNM Comprehensive Cancer Center is the only NCI-designated cancer center in New Mexico, providing comprehensive cancer treatment (chemotherapy, surgery, radiation therapy, immunotherapy), clinical trials, cancer research, survivorship care, and support services. It operates as the oncology specialty hub of the UNM Health Sciences Center, delivering academic, research-backed cancer care to patients across the state, including rural and Native American communities.

Is UNM Comprehensive Cancer Center a public or private company?

UNM Comprehensive Cancer Center is a public company. It is classified as state government owned and is currently operating.

When was UNM Comprehensive Cancer Center founded?

UNM Comprehensive Cancer Center was founded in 1971. It employs 501 to 1,000 people.

Where is UNM Comprehensive Cancer Center based?

UNM Comprehensive Cancer Center is headquartered in Albuquerque, United States, in the North America region.

How does UNM Comprehensive Cancer Center make money?

One revenue line is on record: patient Care Services.

Who are UNM Comprehensive Cancer Center's main competitors?

Stanford Cancer Institute is listed as a broad incumbent. Direct peers are Fred Hutchinson Cancer Center, Mayo Clinic Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center, Huntsman Cancer Institute, Roswell Park Comprehensive Cancer Center, Duke Cancer Institute, Dana-Farber Cancer Institute, MD Anderson Cancer Center and University of Virginia Cancer Center.

Does UNM Comprehensive Cancer Center have an API?

No public API is recorded for UNM Comprehensive Cancer Center.

What industry is UNM Comprehensive Cancer Center in?

UNM Comprehensive Cancer Center's product category is Oncology/Cancer Care Services. Its primary akta.pro industry code is HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation), with a secondary code of HLAFAHAC, Oncology & Cancer Specialty Hospitals. Its NAICS code is 621 and its SIC code is 8093.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals